ArticleFrontiers in nutrition2026
Association of low magnesium status with incident intracranial hemorrhage: a matched-control database study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Magnesium is involved in vascular tone, endothelial function, and coagulation pathways, yet evidence directly linking magnesium status to hemorrhagic cerebrovascular events remains limited. We examined whether chronic low serum magnesium levels are associated with incident nontraumatic intracranial hemorrhage in a large adult population. Methods: This retrospective cohort study used the TriNetX Global Collaborative Network (2010-2024). Low magnesium status was defined as two serum magnesium measurements <1.7 mg/dL within 1 year, and the comparator cohort had two normal values (1.70-2.20 mg/dL). A 3-month landmark design was applied, and 1:1 propensity score matching was performed for demographics, comorbidities, medications, and laboratory markers. The primary outcome was incident nontraumatic intracranial hemorrhage over 5 years. Secondary outcomes included intracerebral hemorrhage, subarachnoid hemorrhage, all-cause mortality, and systolic blood pressure >180 mmHg. Sensitivity, subgroup, and exposure gradient analyses were conducted. Results: After matching, 266,133 patients remained in each group. Low magnesium status was associated with a higher intracranial hemorrhage risk (HR, 1.74; 95% CI, 1.59-1.89; Conclusion: Chronic low serum magnesium levels were associated with an increased risk of intracranial hemorrhage in this observational study. These findings warrant confirmation through prospective studies to clarify whether this association reflects a modifiable risk marker or the underlying illness severity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.